(Total Views: 781)
Posted On: 02/04/2022 6:59:53 AM
Post# of 153911
Re: craigakess #117297
Immu was purchase at a premium of just over 100% or double its stock price which is why I keep trying to temper expectation for a $50 straight buyout price (which is over 80 times ours current stock price). We either need more public news or additional payments will be made after achievement of milestones or revenue targets.
See below
Under the terms of the merger agreement, a wholly-owned subsidiary of Gilead will promptly commence a tender offer to acquire all of the outstanding shares of Immunomedics’ common stock. The $88.00 per share acquisition price represents a 108 percent premium to Immunomedics’ closing price on September 11, 2020.
https://www.gilead.com/news-and-press/press-r...munomedics
IMO
See below
Under the terms of the merger agreement, a wholly-owned subsidiary of Gilead will promptly commence a tender offer to acquire all of the outstanding shares of Immunomedics’ common stock. The $88.00 per share acquisition price represents a 108 percent premium to Immunomedics’ closing price on September 11, 2020.
https://www.gilead.com/news-and-press/press-r...munomedics
IMO
(1)
(0)
